CS logo
small CS logo
Mwanza Intervention Trials Unit

Mwanza, Tanzania
Corporate office
FWR4+4Q4, Mwanza

About Mwanza Intervention Trials Unit


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Mwanza Intervention Trials Unit


During the past decade, Mwanza Intervention Trials Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Mwanza Intervention Trials Unit" #1 collaborator was "Cancer Epidemiology Research Programme Institut Català d' Oncologia" with 1 trials as a collaborator, "Department of Pathology University of Cambridge" with 1 trials as a collaborator, "Karolinska Institute Department of Laboratory Medicine" with 1 trials as a collaborator, "Mwanza Intervention Trials Unit, National Institute for Medical Research" with 1 trials as a collaborator and "York Biomedical Research Institute, Hull York Medical School, University of York" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

Clinical Trials Conditions at Mwanza Intervention Trials Unit


According to Clinical.Site data, the most researched conditions in "Mwanza Intervention Trials Unit" are "Drug-Resistant Tuberculosis" (1 trials), "HPV Infection" (1 trials), "Tuberculosis" (1 trials), "Tuberculosis, MDR" (1 trials) and "Tuberculosis, Multidrug-Resistant" (1 trials). Many other conditions were trialed in "Mwanza Intervention Trials Unit" in a lesser frequency.

Clinical Trials Intervention Types at Mwanza Intervention Trials Unit


Most popular intervention types in "Mwanza Intervention Trials Unit" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bedaquiline" (1 trials), "Gardasil® HPV vaccine" (1 trials), "HR" (1 trials), "HRZE" (1 trials) and "Moxifloxacin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Mwanza Intervention Trials Unit


The vast majority of trials in "Mwanza Intervention Trials Unit" are 1 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Mwanza Intervention Trials Unit


Currently, there are NaN active trials in "Mwanza Intervention Trials Unit". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mwanza Intervention Trials Unit, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mwanza Intervention Trials Unit, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".